Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody
- PMID: 15484283
- PMCID: PMC7166921
- DOI: 10.1002/jmv.20207
Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody
Abstract
High throughput assays for anti-SARS-CoV IgG antibody detection are need for large-scale epidemiologic studies. The performance of a microplate enzyme immunoassay, DETECT-SARS was evaluated for the detection of anti-SARS-CoV IgG antibody. This assay is based on synthetic peptides derived from the nucleocapsid and spike proteins. The results showed that the assay provided a high degree of sensitivity (95.9%) for convalescent serum samples. The level of specificity was close to 90%, and did not show significant variation among different control groups. The high degree of sensitivity together with the high-throughput nature makes it advantageous as a screening assay for studies where handling of a large number of specimens is required.
2004 Wiley-Liss, Inc.
References
-
- Centers for Disease Control and Prevention . 2004. Severe acute respiratory syndrome. http://www.cdc.gov/ncidod/sars/guidance/b/pdf/app1.pdf (assessed on 3 March 2004).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous